Literature DB >> 22844370

Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells.

Xingchuan Wei1, Zhi-Yun DU, Xiao-Xing Cui, Michael Verano, Rong Qing Mo, Zhi Kai Tang, Allan H Conney, Xi Zheng, Kun Zhang.   

Abstract

Curcumin is a non-nutritive yellow pigment found in the spice turmeric, which is derived from the rhizome of the plant Curcuma longa Linn. Six cyclohexanone analogues of curcumin (A(1)-A(6)) were investigated for their effects on growth and apoptosis in PC-3 human prostate cancer cells. The ability of these compounds to inhibit NF-κB activity in PC-3 cells was also determined. Five out of the six curcumin analogues (A(2)-A(6)) had stronger inhibitory effects compared to curcumin on the growth of cultured PC-3 cells. Compounds A(2)-A(6) also had stronger stimulatory effects on apoptosis in PC-3 cells than curcumin, and these curcumin analogues more potently inhibited NF-κB activity than curcumin. The inhibitory effects of these compounds on NF-κB activity correlated with their effects on growth inhibition and apoptosis stimulation in PC-3 cells. The results of the present study provide a rationale for in vivo studies with A(2)-A(6) using suitable animal models of prostate cancer.

Entities:  

Year:  2012        PMID: 22844370      PMCID: PMC3402731          DOI: 10.3892/ol.2012.710

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  46 in total

1.  Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.

Authors:  Alexander Arlt; Andre Gehrz; Susanne Müerköster; Jens Vorndamm; Marie-Luise Kruse; Ulrich R Fölsch; Heiner Schäfer
Journal:  Oncogene       Date:  2003-05-22       Impact factor: 9.867

2.  Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl.

Authors:  Ruby John Anto; Asok Mukhopadhyay; Kate Denning; Bharat B Aggarwal
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

3.  [Curcumin-induced the expression of inhibitor kappaBalpha protein in human prostate cancer cells].

Authors:  Hui Guo; Jian-hua Yu; Ke Chen; Zhang-qun Ye
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2006-09-15

4.  Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.

Authors:  Zhi-Jun Sun; Gang Chen; Wei Zhang; Xiang Hu; Yang Liu; Qian Zhou; Ling-Xing Zhu; Yi-Fang Zhao
Journal:  Mol Pharmacol       Date:  2010-10-19       Impact factor: 4.436

5.  Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.

Authors:  Xi Zheng; Xiao-Xing Cui; Gina E Avila; Mou-Tuan Huang; Yue Liu; Jagruti Patel; Ah Ng Tony Kong; Raphael Paulino; Weichung Joe Shih; Yong Lin; Arnold B Rabson; Bandaru S Reddy; Allan H Conney
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

6.  An evaluation of the anti-neoplastic activity of curcumin in prostate cancer cell lines.

Authors:  Camila B Piantino; Fernanda A Salvadori; Pedro P Ayres; Raphael B Kato; Victor Srougi; Katia R Leite; Miguel Srougi
Journal:  Int Braz J Urol       Date:  2009 May-Jun       Impact factor: 1.541

Review 7.  Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment.

Authors:  Aurelie Cabrespine-Faugeras; Mathilde Bayet-Robert; Jacques-Olivier Bay; Philippe Chollet; Chantal Barthomeuf
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 8.  Curcumin as "Curecumin": from kitchen to clinic.

Authors:  Ajay Goel; Ajaikumar B Kunnumakkara; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

9.  Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents.

Authors:  Guang Liang; Lili Shao; Yi Wang; Chengguang Zhao; Yanhui Chu; Jian Xiao; Yu Zhao; Xiaokun Li; Shulin Yang
Journal:  Bioorg Med Chem       Date:  2008-11-01       Impact factor: 3.641

10.  Dose escalation of a curcuminoid formulation.

Authors:  Christopher D Lao; Mack T Ruffin; Daniel Normolle; Dennis D Heath; Sandra I Murray; Joanne M Bailey; Martha E Boggs; James Crowell; Cheryl L Rock; Dean E Brenner
Journal:  BMC Complement Altern Med       Date:  2006-03-17       Impact factor: 3.659

View more
  13 in total

1.  Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo.

Authors:  Huarong Huang; Xiao-Xing Cui; Shaohua Chen; Susan Goodin; Yue Liu; Yan He; Dongli Li; Hong Wang; Jeremiah Van Doren; Robert S Dipaola; Allan H Conney; Xi Zheng
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

2.  Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation.

Authors:  Hui Guo; Yuemin Xu; Qiang Fu
Journal:  Tumour Biol       Date:  2015-06-02

3.  Curcumin for the Treatment of Prostate Diseases: A Systematic Review of Controlled Clinical Trials.

Authors:  Mohammad Bagherniya; Gholamreza Askari; Babak Alikiaii; Saeed Abbasi; Davood Soleimani; Thozhukat Sathyapalan; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Combination of 12-O-tetradecanoylphorbol-13-acetate with diethyldithiocarbamate markedly inhibits pancreatic cancer cell growth in 3D culture and in immunodeficient mice.

Authors:  Huarong Huang; Kajia Cao; Saquib Malik; Qiuyan Zhang; Dongli Li; Richard Chang; Huaqian Wang; Weiping Lin; Jeremiah Van Doren; Kun Zhang; Zhiyun Du; Xi Zheng
Journal:  Int J Mol Med       Date:  2015-04-01       Impact factor: 4.101

5.  Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures.

Authors:  Dongli Li; Yuran Ma; Wenfeng Liu; Xiang Ren; Min Chen; Xuetao Xu; Zhaojun Sheng; Kun Zhang; Renping Zhou; Susan Goodin; Xi Zheng
Journal:  Int J Med Sci       Date:  2020-07-09       Impact factor: 3.738

6.  Anticarcinogenic Effect of Spices Due to Phenolic and Flavonoid Compounds-In Vitro Evaluation on Prostate Cells.

Authors:  Zuzana Lackova; Hana Buchtelova; Zaneta Buchtova; Borivoj Klejdus; Zbynek Heger; Martin Brtnicky; Jindrich Kynicky; Ondrej Zitka; Vojtech Adam
Journal:  Molecules       Date:  2017-09-28       Impact factor: 4.411

7.  Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells.

Authors:  Huarong Huang; Xuan Chen; Dongli Li; Yan He; Yu Li; Zhiyun Du; Kun Zhang; Robert DiPaola; Susan Goodin; Xi Zheng
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

8.  Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.

Authors:  Huaqian Wang; Xiao-Xing Cui; Susan Goodin; Ning Ding; Jeremiah Van Doren; Zhiyun Du; Mou-Tuan Huang; Yue Liu; Xiaodong Cheng; Robert S Dipaola; Allan H Conney; Xi Zheng
Journal:  Oncol Rep       Date:  2013-11-29       Impact factor: 3.906

9.  Robust volcano plot: identification of differential metabolites in the presence of outliers.

Authors:  Nishith Kumar; Md Aminul Hoque; Masahiro Sugimoto
Journal:  BMC Bioinformatics       Date:  2018-04-11       Impact factor: 3.169

Review 10.  Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer.

Authors:  Quhui Wu; Huiping Ou; Yan Shang; Xi Zhang; Junyong Wu; Fuyuan Fan
Journal:  Drug Des Devel Ther       Date:  2021-06-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.